Collegium Pharmaceutical
COLL
COLL
248 hedge funds and large institutions have $1.49B invested in Collegium Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 230 → 248 (+18)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.72% less ownership
Funds ownership: 121.21% → 119.5% (-1.7%)
Holders
248
Holding in Top 10
1
Calls
$2.65M
Puts
$842K
Top Buyers
| 1 | +$8.88M | |
| 2 | +$8.34M | |
| 3 | +$7.88M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$6.9M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$6.84M |
Top Sellers
| 1 | -$41.9M | |
| 2 | -$31.6M | |
| 3 | -$11.7M | |
| 4 |
BlackRock
New York
|
-$10.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$8.51M |